Heavy chain deposition disease: an overview.
Oe Y, Soma J, Sato H, Ito S.
Clin Exp Nephrol. 2013 Dec;17(6):771-8. doi: 10.1007/s10157-013-0812-x. Epub 2013 May 8.
Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y, Li X, Liang D, Xu F, Liang S, Zhu X, Zheng N, Huang X, Liu Z, Zeng C.
Am J Kidney Dis. 2020 May;75(5):736-743. doi: 10.1053/j.ajkd.2019.08.013. Epub 2019 Nov 5.
A case of heavy-chain deposition disease with good long-term renal survival and a literature review.
Cai X, Zou W, Chen H, Xing C, Yu X.
BMC Nephrol. 2024 Sep 19;25(1):312. doi: 10.1186/s12882-024-03755-z.
Immunoglobulin heavy chain gene rearrangement in heavy chain deposition disease suggests it is a plasma cell disease: a case report.
Rao Q, Xu R, Wan Q.
J Int Med Res. 2022 Mar;50(3):3000605221086428. doi: 10.1177/03000605221086428.
Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA.
Am J Hematol. 2022 Jun 1;97(6):818-829. doi: 10.1002/ajh.26569. Epub 2022 Apr 25.
AL amyloidosis: advances in diagnostics and treatment.
Ryšavá R.
Nephrol Dial Transplant. 2019 Sep 1;34(9):1460-1466. doi: 10.1093/ndt/gfy291.
Immunoglobulin A Heavy Chain Deposition Disease: A Case Report.
Chen Q, Ye JB, Zhong Q.
Iran J Kidney Dis. 2021 Dec;15(6):457-460.
Heavy chain deposition disease: the disease spectrum.
Kambham N, Markowitz GS, Appel GB, Kleiner MJ, Aucouturier P, D'agati VD.
Am J Kidney Dis. 1999 May;33(5):954-62. doi: 10.1016/s0272-6386(99)70432-4.
Renal amyloidosis: an update on diagnosis and pathogenesis.
Gupta N, Kaur H, Wajid S.
Protoplasma. 2020 Sep;257(5):1259-1276. doi: 10.1007/s00709-020-01513-0. Epub 2020 May 24.
Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
Shimamoto Y, Takahashi N, Katoh N, Matsui Y, Mochizuki Y, Ito M, Yazaki M, Kametani F, Kasuno K, Sekijima Y, Naiki H, Iwano M.
BMC Nephrol. 2023 Jun 26;24(1):187. doi: 10.1186/s12882-023-03207-0.
